Portage Biotech Files Form 6-K
Ticker: ATON · Form: 6-K · Filed: Mar 8, 2024 · CIK: 1095435
| Field | Detail |
|---|---|
| Company | Portage Biotech INC. (ATON) |
| Form Type | 6-K |
| Filed Date | Mar 8, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $1.00 m, $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
Portage Biotech filed a 6-K on 3/8/24, standard reporting.
AI Summary
Portage Biotech Inc. filed a Form 6-K on March 8, 2024, to report information for the month of March 2024. The company is incorporated in the British Virgin Islands and its principal executive offices are located in Tortola. This filing is incorporated by reference into their existing registration statements on Form F-3 and Form S-8.
Why It Matters
This filing indicates ongoing reporting requirements for Portage Biotech Inc., which could be relevant for investors tracking the company's regulatory compliance and disclosures.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer and does not contain new material financial or operational information.
Key Players & Entities
- Portage Biotech Inc. (company) — Registrant
- 001-40086 (company) — Commission File Number
- 333-253468 (company) — Form F-3 Registration Statement File Number
- 333-275842 (company) — Form S-8 Registration Statement File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer makes or is required to make public in its home country, or is required to file with a stock exchange on which it is traded.
When was this Form 6-K filed?
This Form 6-K was filed on March 8, 2024.
Where is Portage Biotech Inc. incorporated?
Portage Biotech Inc. is incorporated in the British Virgin Islands.
What are the principal executive office addresses for Portage Biotech Inc.?
The principal executive offices are located at Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110.
Which registration statements does this Form 6-K incorporate by reference?
This Form 6-K is incorporated by reference into Portage Biotech Inc.'s registration statements on Form F-3 (File No. 333-253468) and Form S-8 (File No. 333-275842).
Filing Stats: 712 words · 3 min read · ~2 pages · Grade level 15.2 · Accepted 2024-03-08 17:04:30
Key Financial Figures
- $1.00 m — e Company is not in compliance with the $1.00 minimum bid price requirement for continu
- $1.00 — y's Ordinary Shares must meet or exceed $1.00 per share for a minimum of ten consecut
Filing Documents
- f6k_030824.htm (6-K) — 11KB
- 0001171843-24-001259.txt ( ) — 12KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: March 8, 2024 PORTAGE BIOTECH INC. By: /s/ Allan Shaw Allan Shaw Chief Financial Officer